Works matching IS 16639812 AND DT 2023 AND VI 14
Results: 830
Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1258062
- By:
- Publication type:
- Article
Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1256643
- By:
- Publication type:
- Article
SNPs in cytochrome P450 genes decide on the fate of individuals with genetic predisposition to Parkinson's disease.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1244516
- By:
- Publication type:
- Article
Cost-utility analysis of using paliperidone palmitate in schizophrenia in China.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1238028
- By:
- Publication type:
- Article
The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1237210
- By:
- Publication type:
- Article
Rhizoma Atractylodis Macrocephalae--Assessing the influence of herbal processing methods and improved effects on functional dyspepsia.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1236656
- By:
- Publication type:
- Article
Dapagliflozin versus empagliflozin in patients with chronic kidney disease.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1227199
- By:
- Publication type:
- Article
Subacute toxicity evaluations of LPM3480392 in rats, a full μ-opioid receptor biased agonist.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1218380
- By:
- Publication type:
- Article
Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1217701
- By:
- Publication type:
- Article
Efficacy and safety of total glucosides of paeony in the treatment of recurrent aphthous ulcers: a single-center, double-blind, randomized, placebo-controlled clinical trial.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1209075
- By:
- Publication type:
- Article
Tripterygium glycosides for safely controlling disease activity in systemic lupus erythematosus: a systematic review with meta-analysis and trial sequential analysis.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1207385
- By:
- Publication type:
- Article
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1190402
- By:
- Publication type:
- Article
A review of SARS-CoV-2 drug repurposing: databases and machine learning models.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1182465
- By:
- Publication type:
- Article
Gentiopicroside modulates glucose homeostasis in high-fat-diet and streptozotocin-induced type 2 diabetic mice.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1172360
- By:
- Publication type:
- Article
Therapy by physician-pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1073939
- By:
- Publication type:
- Article
Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using in silico, in vitro and human biomonitoring data.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1165770
- By:
- Publication type:
- Article
Association of thiamine administration and prognosis in critically ill patients with heart failure.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1162797
- By:
- Publication type:
- Article
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1160440
- By:
- Publication type:
- Article
Medicinal plant-based drug delivery system for inflammatory bowel disease.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1158945
- By:
- Publication type:
- Article
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1154377
- By:
- Publication type:
- Article
Ensemble of structure and ligand-based classification models for hERG liability profiling.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1148670
- By:
- Publication type:
- Article
Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1141121
- By:
- Publication type:
- Article
Fraxetin attenuates disrupted behavioral and central neurochemical activity in a model of chronic unpredictable stress.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1135497
- By:
- Publication type:
- Article
Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1127123
- By:
- Publication type:
- Article
Assessment of immunostimulatory responses to the antimiR-22 oligonucleotide compound RES-010 in human peripheral blood mononuclear cells.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1125654
- By:
- Publication type:
- Article
Lipid-engineered nanotherapeutics for cancer management.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1125093
- By:
- Publication type:
- Article
IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1124628
- By:
- Publication type:
- Article
Multi-omics reveals hypertrophy of adipose tissue and lipid metabolism disorder via mitochondria in young mice under real-ambient exposure to air pollution.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1122615
- By:
- Publication type:
- Article
Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1122118
- By:
- Publication type:
- Article
Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management —Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1121950
- By:
- Publication type:
- Article
Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1118358
- By:
- Publication type:
- Article
Case report: A relatively rare adverse event caused by carbetocin— placenta interception.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1112694
- By:
- Publication type:
- Article
Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1111601
- By:
- Publication type:
- Article
Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1105176
- By:
- Publication type:
- Article
Analysis of networks in the dorsolateral prefrontal cortex in chronic schizophrenia: Relevance of altered immune response.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1003557
- By:
- Publication type:
- Article
An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1099380
- By:
- Publication type:
- Article
Random effects modelling versus logistic regression for the inclusion of cluster-level covariates in propensity score estimation: A Monte Carlo simulation and registry cohort analysis.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.988605
- By:
- Publication type:
- Article
Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1075010
- By:
- Publication type:
- Article
Spider venom-derived peptide JZTX-14 prevents migration and invasion of breast cancer cells via inhibition of sodium channels.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1067665
- By:
- Publication type:
- Article
Quantitative proteomics reveals Polygonum perfoliatum L. ameliorates hepatic steatosis by promoting PPARs/CPT1A/ CPT2-mediated fatty acid β-oxidation.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1016129
- By:
- Publication type:
- Article
Caryopteris odorata and its metabolite coumarin attenuate characteristic features of cardiometabolic syndrome in high-refined carbohydrate-high fat-cholesterol-loaded feed-fed diet rats.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1097407
- By:
- Publication type:
- Article
The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1091718
- By:
- Publication type:
- Article
Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1200491
- By:
- Publication type:
- Article
Editorial: Women in neuropharmacology: 2021.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1198876
- By:
- Publication type:
- Article
Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1198151
- By:
- Publication type:
- Article
Editorial: Liquid biopsy as a tool for precision oncology: New challenges to assess clinical response, Volume II.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1192549
- By:
- Publication type:
- Article
Editorial: Emerging talents in pharmacology of ion channels and channelopathies 2022.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1191328
- By:
- Publication type:
- Article
Editorial: Women in obstetric and pediatric pharmacology: 2021.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1191285
- By:
- Publication type:
- Article
Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1184914
- By:
- Publication type:
- Article
I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1183052
- By:
- Publication type:
- Article